Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¾ÇÇϼ±¿¡¼­ ºÐ¸®µÈ NGF¿¡ ÀÇÇØ À¯µµµÇ´Â ºñ¸¸¼¼Æ÷ È°¼ºÈ­¿¡ ¹ÌÄ¡´Â »ó¹éÇÇÀÇ ¾ïÁ¦È¿°ú

INHIBITOR EFFECTS OF CORTEX MORI ON SUBMANDIBULAR GLAND-DRIVED-NERVE GROWTH FACTOR-INDUCED MAST CELL ACTIVATION

´ëÇѼҾÆÄ¡°úÇÐȸÁö 1993³â 20±Ç 2È£ p.535 ~ 553
Á¤ÈïÁÖ, ±è´ë¹ü, È«¼º¿ì,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤ÈïÁÖ (  ) - ÀüºÏ´ëÇб³ Ä¡°ú´ëÇÐ ¼Ò¾ÆÄ¡°úÇб³½Ç
±è´ë¹ü (  ) - ÀüºÏ´ëÇб³ Ä¡°ú´ëÇÐ ¼Ò¾ÆÄ¡°úÇб³½Ç
È«¼º¿ì (  ) - ÀüºÏ´ëÇб³ Ä¡°ú´ëÇÐ ¼Ò¾ÆÄ¡°úÇб³½Ç

Abstract

°á·Ð
»ó¹éÇÇ°¡ NGF¿¡ ÀÇÇÑ ÈòÁã º¹°­ ºñ¸¸¼¼Æ÷ È°¼ºÈ­¿¡ ¹ÌÄ¡´Â ¿µÇâ°ú NGF¿¡ ÀÇÇÑ ÇǺιÝ
ÀÀ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ¾Ë¾Æº¸±â À§ÇÏ¿© ºñ¸¸¼¼Æ÷ Å»°ú¸³ À¯¹«, È÷½ºÅ¸¹Î À¯¸® ¹× ¼¼Æ÷³»·ÎÀÇ
Ä®½· À¯ÀÔ·®°ú ÇǺιÝÀÀÀ» ÃøÁ¤ÇÑ °á°ú ´ÙÀ½ÀÇ ½ÇÇè°á°ú¸¦ ¾ò¾ú´Ù.
1. NGF¿¡ ÀÇÇÑ ºñ¸¸¼¼Æ÷ÀÇ Å»°ú¸³À» 10ºÐ À̳»¿¡ °üÂûµÇ¾ú°í, ÀÌ·¯ÇÑ Å»°ú¸³Àº »ó¹éÇÇ
Àü󸮿¡ ÀÇÇÏ¿© ¾ïÁ¦µÇ¾ú´Ù.
2. ºñ¸¸¼¼Æ÷¿¡ NGF¸¦ ´Üµ¶À¸·Î ó¸®ÇÑ °æ¿ìÀÇ ºñ¸¸¼¼Æ÷ Å»°ú¸³±º¿¡ ºñÇÏ¿© »ó¹éÇǸ¦ Àü
ó¸®ÇÑ ÈÄ¿¡ NGF¸¦ ÷°¡ÇÑ °æ¿ì¿¡¼­ ºñ¸¸¼¼Æ÷ Å»°ú¸³·üÀÌ ÇöÀúÇÏ°Ô ¾ïÁ¦µÇ¾ú´Ù.
3. NGF¿¡ ÀÇÇÑ ºñ¸¸¼¼Æ÷·ÎºÎÅÍÀÇ È÷½ºÅ¸¹Î À¯¸®´Â ¿ë·® ÀÇÁ¸¼º ¾ç»óÀ¸·Î Áõ°¡µÇ¾úÀ¸¸ç,
º¹°­ ºñ¸¸ ¼¼Æ÷¿¡ NGF¸¦ ´Üµ¶À¸·Î ó¸®ÇÑ °æ¿ìÀÇ ºñ¸¸¼¼Æ÷ È÷½ºÅ¸¹Î À¯¸®À²¿¡ ºñÇÏ¿© »ó
¹éÇǸ¦ Àüó¸®ÇÑ ÈÄ¿¡ NGF¸¦ ÷°¡ÇÑ °æ¿ì¿¡¼­ ºñ¸¸¼¼Æ÷ È÷½ºÅ¸¹Î À¯¸®À²ÀÌ ÇöÀúÇÏ°Ô ¾ïÁ¦
µÊÀ» º¸¿© ÁÖ¾ú´Ù.
4. ºñ¸¸¼¼Æ÷¿¡ ó¸®µÈ NGF´Â ºñ¸¸¼¼Æ÷³»·ÎÀÇ Ä®½· À¯ÀÔ·®À» Áõ°¡½ÃÄ×À¸¸ç, »ó¹éÇÇ´Â
NGF¿¡ ÀÇÇÑ º¹°­ ºñ¸¸¼¼Æ÷ÀÇ Ä®½· À¯ÀÔÀ» ÇöÀúÇÏ°Ô ¾ïÁ¦ÇÏ¿´´Ù.
5. Sprague-Dawley°è ÈòÁã¿¡¼­ NGF¿¡ ÀÇÇÏ¿© À¯¹ßµÈ ÇǺιÝÀÀÀº »ó¹éÇÇÀÇ Àü󸮿¡ ÀÇ
ÇÏ¿© ÇöÀúÇÏ°Ô ¾ïÁ¦µÇ¾ú´Ù.
ÀÌ»óÀÇ °á°ú·Î »ó¹éÇÇ´Â NGF¿¡ ÀÇÇÑ ¼¼Æ÷³»·ÎÀÇ Ä®½· À¯ÀÔÀ» ÇöÀúÈ÷ °¨¼Ò½ÃÅ´À¸·Î½á
NGF¿¡ ÀÇÇÑ º¹°­ ºñ¸¸¼¼Æ÷ Å»±«¸³ ¹× È÷½ºÅ¸¹Î À¯¸®¸¦ °­·ÂÈ÷ ¾ïÁ¦ÇÏ°í, NGF¿¡ ÀÇÇÑ ÇÇ
ºÎ ¹ÝÀÀÀ» ¾ïÁ¦ÇÏ´Â ºñ¸¸¼¼Æ÷ È°¼º¾ïÁ¦ ÀÛ¿ëÀÌ ÀÖ´Â ¹°ÁúÀ» ÇÔÀ¯ÇÏ°í ÀÖ´Ù°í »ç·áµÈ´Ù.
#ÃÊ·Ï#
Cortex Mori(Norus alba L.), the root bark of mulberry tree has been used as an
antiphlogistic, diuretic, and expectorant in herbal medicine. Previous studies have
demonstrated that Cortex Mori had inhibitory effects on the compound 48/80-induced
degranulation and histamine release from rat peritoneal mast cells(RPMC). The purpose
of this study is to determine whether Cortex Mori(CM) could inhibit the nerve growth
factor(NGF)-induced activation of RPMC in vivo and in vitro. In vitro, various
concentrations of NGF(0.1, 1, 10 and 1000ug/ml) were added into the RPMC suspension
(106 cells/ml) pretreated with lyso-PS at 37¡É for 10 minutes. Cortex Mori
pretreatment was performed before or after lyso-PS treatment at 37¡É for 10 minutes.
Histamine in the supernatants and calcium uptake of RPMC were measured by
radioisotope enzymatic histamine assay and radioisotope calcium uptake method. In vivo
experiment, to estimate the effect of Cortex Mori on NGF-induced cutaneous reaction,
various doses of NGF with or without Cortex Mori were injected i.d. int the shaved
flank of Sprague-Dawley rats, and the blue cutaneous staining induced by Evans' blue
injection at the NGF alone Cortex Mori plus NGF injection sites were observed. Results
were 1) the NGF-induced degranulation and histamine release of RPMC pretreated with
Cortex Mori were significantly inhibited, compared to those of control without Cortex
Mori pretreatment, 2) Cortex Mori inhibited the NGF-induced cutaneous reaction
remarkably. From the above results, it is suggested that Cortex Mori contains some
substances with an activity to inhibit the NGF-induced activation of mast cell.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI